KOLMAR BNH EXPEDITES EUROPEAN MARKET EXPANSION WITH ITS TECHNOLOGY-DRIVEN HEMOHIM G

 

_{HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Photo: Kolmar BNH)}

SEOUL, South Korea, July 25 (Bernama-BUSINESS WIRE) -- Kolmar BNH (KRX: 200130), a leading Korean health functional food Original Development Manufacturing (ODM) firm, is accelerating its expansion efforts into the Southeast Asian and European markets with HemoHIM G, a product designed for the global arena.
 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240724688710/en/ 

HemoHIM G (Global) is the international version of ‘HemoHIM’, Korea’s first individually-approved immune-boosting health supplement developed by Kolmar BNH over an eight-year period. The formulation has been tailored to comply with the food regulations of various countries, with adjustments made to raw materials and ingredient ratios. The product features angelica sinensis, ligusticum chuanxiong, paeonia lactiflora, all selected through rigorous quality control processes. Enhanced taste and aroma also make HemoHIM G more appealing to a broader audience.

In April, Kolmar BNH published a study on HemoHIM G in the SCIE-ranked journal Toxicological Research, demonstrating its safety. Conducted according to OECD guidelines, the study holds significance not only in facilitating safety approvals in other countries but also in reinforcing intellectual property rights with reliable results.

http://mrem.bernama.com/viewsm.php?idm=49049